IOTA Pharmaceuticals


IOTA Pharmaceuticals
Fragment - based Drug Discovery
GBM Drug Bank
Glioma & Glioblastoma
WINDOW on Glioblastoma
About IOTA Drug Descovery and Development Partnership

IOTA's Drug Discovery Partnerships are designed for groups seeking to move rapidly and cost effectively from validated target to hit molecules or looking to find new hits within novel, patentable chemical space.

Whether your target has structural information or only information about existing ligands or even just low affinity fragments, IOTA’s screening tools can identify lead fragments, incorporate these into novel scaffold structures, and design potent, selective, and orally bioavailable lead compounds.

For more information contact